Berry Genomics Co.,Ltd (SHE:000710)

China flag China · Delayed Price · Currency is CNY
15.79
+1.44 (10.03%)
Aug 22, 2025, 3:04 PM CST
10.03%
Market Cap5.58B
Revenue (ttm)1.02B
Net Income (ttm)-207.13M
Shares Out353.52M
EPS (ttm)-0.63
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume74,993,750
Average Volume34,190,752
Open14.32
Previous Close14.35
Day's Range14.26 - 15.79
52-Week Range6.66 - 19.55
Beta0.40
RSI64.38
Earnings DateAug 30, 2025

About Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well a... [Read more]

Sector Healthcare
Founded 1997
Employees 1,402
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000710
Full Company Profile

Financial Performance

In 2024, Berry Genomics Co.,Ltd's revenue was 1.08 billion, a decrease of -6.36% compared to the previous year's 1.15 billion. Losses were -192.43 million, -54.96% less than in 2023.

Financial Statements

News

There is no news available yet.